Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
The Technology & Commercialization Board, also known as Innovative Ventures, was founded in 1986 by Tom Nastas and is based in Kazakhstan. This venture capital firm operates internationally, focusing on investment and fund management for emerging companies. It aims to support underserved and under-financed entrepreneurs across Europe, North America, Russia, and Sub-Saharan Africa.
Innovative Ventures invests in a variety of sectors, providing venture capital, growth capital, and commercialization support. Their investment strategy covers stages from innovation grants to Series D funding, with check sizes ranging from $100,000 to $10 million. The firm emphasizes aligning capital types with the specific growth stages and risks of the companies they support.
Innovative Ventures has backed notable companies including Neogen Corp., a leader in food safety with a $3.2 billion exit. Other portfolio companies include Applied Intelligence Systems Inc., acquired by ESI, and Personal Bibliographic Systems Inc., acquired by Thompson Financial. They also invested in Flexoprint, a printing business in Russia, and MRCI, a seafood processing company with a global market presence.
Submit your pitch through their form at scalingupinnovation.com.
Yes, Innovative Ventures often leads funding rounds, particularly in the early stages of company development.
The firm is open to follow-on investments, especially for companies that demonstrate significant growth potential and alignment with their investment thesis.
The firm manages a diverse portfolio with the ability to invest between $100,000 and $10 million, but specific fund size details are not disclosed.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.